Found: 31
Select item for more details and to access through your institution.
Letter: Post‐COVID‐19 disorders of gut–brain interaction (DGBI)—just post‐infectious or a multifaceted entity? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 132, doi. 10.1111/apt.17561
- By:
- Publication type:
- Article
Letter: Post‐COVID‐19 functional dyspepsia and irritable bowel syndrome—Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Letter: Mendelian randomization ‐ new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 145, doi. 10.1111/apt.17552
- By:
- Publication type:
- Article
Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 139, doi. 10.1111/apt.17571
- By:
- Publication type:
- Article
Editorial: The US burden of HRS‐AKI—Putting numbers to the problem: Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 137, doi. 10.1111/apt.17559
- By:
- Publication type:
- Article
Letter: childhood recurrent abdominal pain is associated with increased duodenal eosinophilia independent of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 134, doi. 10.1111/apt.17556
- By:
- Publication type:
- Article
Letter: for improved prognostic value, use MAFLD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 147, doi. 10.1111/apt.17558
- By:
- Publication type:
- Article
Editorial: risk of renal function decline in patients with chronic hepatitis B virus infection treated with nucleos(t)ide analogues.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
AP&T: Editorsʼ declarations of interest.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 4, doi. 10.1111/apt.17550
- Publication type:
- Article
Letter: Post‐COVID‐19 disorders of gut‐brain interaction (DGBI)—Just post‐infectious or a multi‐faceted entity?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 130, doi. 10.1111/apt.17549
- By:
- Publication type:
- Article
Letter: expanding the role for decision aids in IBD into pregnancy‐related topics.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 141, doi. 10.1111/apt.17545
- By:
- Publication type:
- Article
Editorial: elderly onset inflammatory bowel disease ‐ clues from the largest population‐based cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: The US burden of HRS‐AKI—Putting numbers to the problem.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: faecal incontinence in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 114, doi. 10.1111/apt.17540
- By:
- Publication type:
- Article
Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 99, doi. 10.1111/apt.17532
- By:
- Publication type:
- Article
Non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 80, doi. 10.1111/apt.17515
- By:
- Publication type:
- Article
Letter: Post‐COVID‐19 functional dyspepsia and irritable bowel syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Editorial: pharmacokinetic and pharmacodynamic model for vonoprazan—a step forward to precision medicine.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Letter: Mendelian randomization—New perspective in inflammatory bowel disease and pancreatic cancer?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 143, doi. 10.1111/apt.17537
- By:
- Publication type:
- Article
Editorial: non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: improving the use of Montreal classification through a bidirectional approach.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA‐SWITCH study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 60, doi. 10.1111/apt.17525
- By:
- Publication type:
- Article
Population‐attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi‐ethnic cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 89, doi. 10.1111/apt.17523
- By:
- Publication type:
- Article
Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries—A nationwide cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 48, doi. 10.1111/apt.17520
- By:
- Publication type:
- Article
Meta‐analysis: Post‐COVID‐19 functional dyspepsia and irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 6, doi. 10.1111/apt.17513
- By:
- Publication type:
- Article
Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5‐year follow‐up data from the prospective BioCrohn study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 35, doi. 10.1111/apt.17512
- By:
- Publication type:
- Article
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 71, doi. 10.1111/apt.17507
- By:
- Publication type:
- Article
A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 16, doi. 10.1111/apt.17510
- By:
- Publication type:
- Article
The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: A cross‐sectional study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 26, doi. 10.1111/apt.17502
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 1, doi. 10.1111/apt.17015
- Publication type:
- Article